Authors: SINGH GJP FLEISCHER N LESKO L WILLIAMS R

Citation: Gjp. Singh et al., EVALUATION OF THE PROPOSED FDA PILOT DOSE-RESPONSE METHODOLOGY FOR TOPICAL CORTICOSTEROID BIOEQUIVALENCE TESTING, Pharmaceutical research, 15(1), 1998, pp. 4-5

Authors: ELTAHTAWY AA TOZER TN HARRISON F LESKO L WILLIAMS R

Citation: Aa. Eltahtawy et al., EVALUATION OF BIOEQUIVALENCE OF HIGHLY VARIABLE DRUGS USING CLINICAL-TRIAL SIMULATIONS - II - COMPARISON OF SINGLE AND MULTIPLE-DOSE TRIALSUSING AUC AND CMAX, Pharmaceutical research, 15(1), 1998, pp. 98-104

Authors: TAKAMATSU N WELAGE LS IDKAIDEK NM LIU DY LEE PID HAYASHI Y RHIE JK LENNERNAS H BARNETT JL SHAH VP LESKO L AMIDON GL

Citation: N. Takamatsu et al., HUMAN INTESTINAL PERMEABILITY OF PIROXICAM, PROPRANOLOL, PHENYLALANINE, AND PEG-400 DETERMINED BY JEJUNAL PERFUSION, Pharmaceutical research, 14(9), 1997, pp. 1127-1132

Authors: SKELLY JP VANBUSKIRK GA ARBIT HM AMIDON GL AUGSBURGER L BARR WH BERGE S CLEVENGER J DIGHE S FOX D GONZALEZ MA GRAY VA HOIBERG C JERUSSI R LEESON LJ LESKO L MALINOWSKI H NIXON PR PEARCE DM PECK G PORTER S ROBINSON J SAVELLO DR SCHWARTZ P SCHWARTZ JB SHAH VP THEEUWES F WHEATLEY T

Citation: Jp. Skelly et al., WORKSHOP-II REPORT - SCALE-UP OF ORAL EXTENDED-RELEASE DOSAGE FORMS, European journal of pharmaceutics and biopharmaceutics, 39(4), 1993, pp. 162-167

Authors: SKELLY JP VANBUSKIRK GA ARBIT HM AMIDON GL AUGSBURGER L BARR WH BERGE S CLEVENGER J DIGHE S FAWZI M FOX D GONZALEZ MA GRAY VA HOIBERG C LEESON LJ LESKO L MALINOWSKI H NIXON PR PEARCE DM PECK G PORTER S ROBINSON J SAVELLO DR SCHWARTZ P SCHWARTZ JB SHAH VP SHANGRAW R THEEUWES F WHEATLEY T

Citation: Jp. Skelly et al., SCALEUP OF ORAL EXTENDED-RELEASE DOSAGE FORMS, Pharmaceutical research, 10(12), 1993, pp. 1800-1807